Glenmark Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2025.

Corporate Actions View source PDF Explain this filing

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.3%Reaction day

₹1919.70

prior close

₹1918.10

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.7%-1.5% vs market

Pharmaceuticals peers, median of 150sector+0.8%-0.5% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Midcap 150 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

+0.7

15m

+0.7

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.3+1.7-1.5+0.8-0.5

Next day

-0.0+1.9-1.9+0.7-0.7

+4.5+2.6+1.9+1.3+3.2

+4.0+2.0+2.0+1.0+3.0

+7.0+2.0+5.0+1.1+5.9

+7.1+2.4+4.7+1.5+5.6

+11.0+3.6+7.3+1.8+9.2

15d

+5.3+5.0+0.4+2.1+3.2

+2.0+2.3-0.3-0.6+2.5

-1.2+7.1-8.3+0.4-1.6

+1.4+7.8-6.4-3.9+5.3

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Glenmark Pharmaceuticals has fixed September 26, 2025 (2:00 p.m. IST) as the date for its 47th Annual General Meeting, to be held via video conferencing. The record date for the purpose of dividend has been set as September 15, 2025. Shareholders on the register as of that date will receive a dividend of ₹2.50 per equity share for FY ending March 31, 2025, subject to AGM approval. The AGM will also consider the appointment of Walker Chandiok & Co. LLP as new statutory auditors for a five-year term (proposed FY26 audit fee of ₹16 million), ratification of cost auditor remuneration of ₹2.80 million, appointment of Rauthan & Associates as secretarial auditor for five years, and appointment of Ms. Patricia Andrews as a Non-Executive Independent Director for five years from August 14, 2025.

Likely market impact

Investors need to hold Glenmark shares by September 15, 2025 to be eligible for the ₹2.50 per share dividend. The change in statutory auditor from Suresh Surana & Associates to Walker Chandiok & Co. LLP marks a notable governance change, while the continuity of dividend payment signals steady shareholder returns.